Nexeon MedSystems, Inc. announced that it has entered into a securities purchase agreement for a private placement of a senior secured convertible promissory note, commitment shares and warrants for gross proceeds of $1,000,000 with accredited investor, Leonite Capital LLC on August 21, 2017. The company will issue a convertible promissory note for proceeds of $1,000,000 and 100,000 commitment shares. The note carries a fixed coupon of 12% per annum and would mature in 24 months. The note is convertible into common shares of the company at a conversion price of $1.75 per share. The note may not be prepaid in whole or in part. Any amount of principal or interest on the note, which is not paid by the maturity date, shall bear interest at the rate of 24% per annum from the due date thereof until the same is paid. The note is issued at an original issue discount of 120,000. The company will also issue 250,000 warrants to purchase number of common shares at an exercise price of $2.50 per share for a period of two years from the date of closing and 250,000 warrants to purchase number of common shares at an exercise price of $3 per share for a period of five years from the date of closing. The company will issue the securities pursuant to exemption provided under Regulation D. The company shall reimburse the buyer for expenses incurred by them, amounting to $20,000. On November 20, 2018, the company announced that it has extended the maturity date of the note to December 31, 2019.